Skip to content

Author

Daniel Gaudet

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria.

As the diagnosis of HoFH continues to evolve, future diagnostic criteria should place less emphasis on genetics and greater emphasis on modern clinical applications to ensure that all individuals with HoFH have access to the most appropriate therapies to reduce their risk of premature ASCVD and death resulting from pro...

Daniel Gaudet, R. Godin, R. Rosenson et al. · 0 citations
Jul 2026

Longer-Term Efficacy and Safety of Zodasiran in Patients with Mixed Hyperlipidaemia.

BACKGROUND Mixed hyperlipidaemia, characterized by elevated cholesterol and triglyceride levels, is associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). Angiopoietin-like protein 3 (ANGPTL3) regulates lipid metabolism through inhibition of lipoprotein and endothelial lipases. Loss-of-functi...

Robert S. Rosenson, Daniel Gaudet, Christie M. Ballantyne et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.